Metraipolis › archive › dc_80912ebef846

Predictive Screening of Ta4C3 MXene as an Inhalable Nanotherapeutic Based on an Advanced 3D Air-Liquid Interface Lung Model — Europe PMC PMID:41925143

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41925143
DOI
10.1021/acsnano.6c03602
License (as archived)
solo-consultazione
Archived
2026-11-03T10:20:04.942Z
SHA-256 of the archived text
08d4e9f8f1105820eeee642516ca6a73e10efdbca12efd34d973d280223ee352
Stable URL of this page
https://metraipolis.com/documento/dc_80912ebef846

How to cite

Predictive Screening of Ta4C3 MXene as an Inhalable Nanotherapeutic Based on an Advanced 3D Air-Liquid Interface Lung Model — Europe PMC PMID:41925143 — Europe PMC (en), https://europepmc.org/article/MED/41925143 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_80912ebef846 (Metraipolis archive dc_80912ebef846, sha256 08d4e9f8f1105820eeee642516ca6a73e10efdbca12efd34d973d280223ee352)
BibTeX
@misc{dc80912ebef846,
  title = {Predictive Screening of Ta4C3 MXene as an Inhalable Nanotherapeutic Based on an Advanced 3D Air-Liquid Interface Lung Model — Europe PMC PMID:41925143},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41925143},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_80912ebef846; sha256 08d4e9f8f1105820eeee642516ca6a73e10efdbca12efd34d973d280223ee352},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41925143. Agents can read the archived copy with the MCP tool read_document.